EUVIMEDOpdag EUVIMED
Crossref

Preliminary Investigation into the Anti-Tumor Mechanism of Ganoderma lucidum Crude Polysaccharides-tes

Jingxia Liu, Yanyan Zhao

Global Biomedical Frontiers · 2026-07-28 · 2 (1)

DOI: 10.67206/ch221f89 ↗

At a glance

Journal article in Global Biomedical Frontiers, published online on 2026-07-28. Written by Jingxia Liu and 1 co-authors. 9 references.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

This study aims to explore the potential anti-tumor mechanisms of Ganoderma Lucidum Polysaccharide (GLP). Flow cytometry was employed to investigate the activation effects of GLP on different immune cell subsets. The direct inhibitory effects of GLP on tumor cells were evaluated using CCK assay, MTT assay, and real-time cell monitoring (Cell Index) methods. Additionally, the cytotoxic effects of GLP on cancer-associated fibroblasts (CAF) were examined. A hypothesis was proposed that GLP inhibits tumor development by improving the tumor microenvironment. The results indicate that GLP exerts anti-tumor effects not only by directly killing tumor cells but also by inhibiting the growth of CAFs and primarily promoting CD4+ T cell proliferation.

Cite

APA

Liu, J., & Zhao, Y. (2026). Preliminary Investigation into the Anti-Tumor Mechanism of Ganoderma lucidum Crude Polysaccharides-tes. Global Biomedical Frontiers, 2(1). https://doi.org/10.67206/ch221f89

Vancouver

Liu J, Zhao Y. Preliminary Investigation into the Anti-Tumor Mechanism of Ganoderma lucidum Crude Polysaccharides-tes. Global Biomedical Frontiers. 2026;2(1). doi:10.67206/ch221f89

BibTeX
@article{Liu2026,
  author = {Liu, Jingxia and Zhao, Yanyan},
  title = {Preliminary Investigation into the Anti-Tumor Mechanism of Ganoderma lucidum Crude Polysaccharides-tes},
  journal = {Global Biomedical Frontiers},
  year = {2026},
  volume = {2},
  number = {1},
  doi = {10.67206/ch221f89}
}
Start for free →